Eiger BioPharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Eiger BioPharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$12.6M, a 48.5% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$71.8M, a 22.6% increase year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$71.8M, a 22.6% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$92.7M, a 20.5% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$76.9M, a 23.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$71.8M +$21M +22.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 -$92.7M -$15.8M -20.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 -$76.9M -$14.8M -23.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 -$62.1M +$6.76M +9.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 -$68.9M -$17.9M -35% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 -$51M -$9.53M -22.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 -$41.5M +$4.6M +9.97% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 -$46.1M -$33.1M -256% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 -$13M -$11.5M -756% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 -$1.52M -$563K -59.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
2013 -$953K +$15M +94% Jan 1, 2013 Dec 31, 2013 8-K/A 2016-06-17
2012 -$15.9M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.